Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their
Investment in Dynavax Technologies Corporation of Class Action Lawsuit and
Deadline of August 19, 2013 to Seek Lead Plaintiff Position -- DVAX

NEW YORK, June 19, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a
class action lawsuit has been commenced in the United States District Court
for the Northern District of California on behalf of investors who purchased
Dynavax Technologies Corporation ("Dynavax" or the "Company") (Nasdaq:DVAX)
stock between April 26, 2012 and June 10, 2013.

For more information, click here:

The complaint alleges that defendants violated federal securities laws by
issuing materially false and misleading statements concerning the viability of
their drug HEPLISAV. In particular, it is alleged that during the Class Period
Dynavax concealed from the public that: (1) the clinical trial for HEPLISAV
was flawed because it was not representative of the US population and lacked
information regarding concomitant use of HEPLISAV with other vaccines; (2)
Dynavax failed to provide the FDA with sufficient data concerning its
manufacturing processes and controls for HEPLISAV.

On June 10, 2013, Dynavax disclosed that the FDA required additional data
regarding the safety of HEPLISAV before it could further review the drug for
potential approval.

If you suffered a loss in Dynavax you have until August 19, 2013 to request
that the Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To obtain
additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free: (877) 363-5972
         Fax: (866) 367-6510
Sponsored Links
Sponsored Links